학술논문
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
Document Type
Article
Author
Margolis, David A; Gonzalez-Garcia, Juan; Stellbrink, Hans-Jürgen; Eron, Joseph J; Yazdanpanah, Yazdan; Podzamczer, Daniel; Lutz, Thomas; Angel, Jonathan B; Richmond, Gary J; Clotet, Bonaventura; Gutierrez, Felix; Sloan, Louis; Clair, Marty St; Murray, Miranda; Ford, Susan L; Mrus, Joseph; Patel, Parul; Crauwels, Herta; Griffith, Sandy K; Sutton, Kenneth C; Dorey, David; Smith, Kimberly Y; Williams, Peter E; Spreen, William R
Source
In The Lancet 23-29 September 2017 390(10101):1499-1510
Subject
Language
ISSN
0140-6736